Geron Corp Q1 2025 10-Q Filing
Ticker: GERN · Form: 10-Q · Filed: May 7, 2025 · CIK: 886744
| Field | Detail |
|---|---|
| Company | Geron Corp (GERN) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Geron Corp's Q1 2025 10-Q is in. Financials are updated.
AI Summary
Geron Corporation filed its 10-Q for the period ending March 31, 2025. The company reported financial results for the first quarter of 2025, detailing its revenue streams, operating expenses, and overall financial position. Key financial data and operational highlights for the period are presented in this filing.
Why It Matters
This filing provides investors with an update on Geron Corp's financial health and operational performance for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Geron Corp faces inherent risks related to drug development, regulatory approvals, and market competition, which are reflected in its financial filings.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Quarterly financial reporting)
- 2025-05-07 — Filing Date (Date the 10-Q was submitted to the SEC)
- 2024-12-31 — Prior Year End Date (Comparison point for financial statements)
- 2024-01-01 to 2024-03-31 — Q1 2024 Period (Previous year's first quarter for comparison)
- 2025-01-01 to 2025-03-31 — Q1 2025 Period (Current year's first quarter)
Key Players & Entities
- GERON CORP (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250507 (date) — Filing Date
- 919 EAST HILLSDALE BOULEVARD (address) — Business and Mail Address
- FOSTER CITY, CA (location) — Business and Mail City/State
- PHARMACEUTICAL PREPARATIONS [2834] (industry) — Standard Industrial Classification
FAQ
What were Geron Corp's total revenues for the first quarter of 2025?
The filing indicates periods for revenue reporting, but specific dollar amounts for Q1 2025 revenues are not detailed in the provided header information.
What is Geron Corp's primary business segment?
Geron Corp's Standard Industrial Classification is 'PHARMACEUTICAL PREPARATIONS [2834]', indicating its primary business is in this sector.
When was the company's last name change?
The company's former name was GERON CORPORATION, and the date of the name change was 19960521.
What is the company's fiscal year end?
Geron Corp's fiscal year ends on December 31st.
Where is Geron Corp headquartered?
Geron Corp's business and mail address is 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA 94404.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding GERON CORP (GERN).